Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ayalla is a Brazilian company specializing in the distribution and supply of high-quality raw materials for the pharmaceutical, nutraceutical, food, and cosmetic industries. Founded in 1994, the company acts as a strategic bridge between global manufacturers and the Brazilian market, providing technical support and regulatory compliance for imported ingredients. Their portfolio includes a wide range of active pharmaceutical ingredients (APIs), excipients, and specialized additives. Ayalla is recognized for its focus on quality control and its ability to navigate the complex regulatory landscape of the Brazilian Health Regulatory Agency (ANVISA).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ayalla.